Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

atnahs pharma uk limited, united kingdom - tetracosactide - suspension for injection - 1 mg/ml

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dechra regulatory b.v. - tetracosactide hexaacetate 0,28 mg/ml - eq. tetracosactide 0,25 mg/ml - solution for injection - 0,25 mg/ml - tetracosactide hexaacetate 0.28 mg/ml - tetracosactide - dog

Ireland - English - HPRA (Health Products Regulatory Authority)

defiante farmaceutica, s.a. - tetracosactide acetate - solution for injection - 250 mcg/ml microgram/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - tetracosactide 0.25 mg/ml equivalent to tetracosactide hexaacetate 0.28 mg/ml - solution for injection - 0.25 mg/ml - active: tetracosactide 0.25 mg/ml equivalent to tetracosactide hexaacetate 0.28 mg/ml excipient: acetic acid sodium acetate trihydrate sodium chloride water for injection - for the investigation of adrenocortical insufficiency

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - tetracosactide 1 mg/ml equivalent to tetracosactide hexaacetate 1.12 mg/ml - injection (depot) - 1 mg/ml - active: tetracosactide 1 mg/ml equivalent to tetracosactide hexaacetate 1.12 mg/ml excipient: benzyl alcohol dibasic sodium phosphate dodecahydrate hydrochloric acid sodium chloride sodium hydroxide water for injection zinc chloride - diagnostic use for the investigation of adrenocortical insufficiency: a 5-hour test canbe peerformed using synacthen depot when the 30-minute test with synacthen i.m./i.v. gives inconclusive results, or if the aim is to determine the functional reserve of the adrenal cortex.